Adagene ADAG
NASDAQ ADAG
$3.62 -0.07 (-1.89%)
As of: Sep 4, 2026 · 2:49 PM EDT

Adagene (ADAG) Total Debt (2019 - 2026)

Adagene (ADAG) posted quarterly Total Debt of $1849.5 billion for Q4 2025, down 86.14% year-over-year from $13340.9 billion in Q4 2024, and up 40738566.17% quarter-over-quarter from $4.5 million in Q2 2025.

Analysis

Adagene (ADAG) Total Debt (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Total Debt for 7 consecutive years, with $1849.5 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Total Debt fell 86.14% year-over-year to $1849.5 billion; the TTM figure through Dec 2025 stood at $1849.5 billion (down 86.14% YoY), while the FY2025 annual figure was $1849.5 billion, down 86.14% from the prior year.
  • Total Debt rose to $1849.5 billion in Q4 2025 per ADAG's latest filing, from $4.5 million in the prior quarter.
  • Across five years, Total Debt topped out at $17701.6 billion in Q4 2023 and bottomed at $3.4 million in Q4 2021.
  • Historically, Total Debt has averaged $7644.4 billion across 5 years, with a median of $6231.0 billion in 2022.
  • Annual changes were most pronounced in 2022 — Total Debt soared 507243989.22% — and 2024, when it sank 100.0%.
  • Adagene's Total Debt stood at $3.4 million in 2021, then jumped by 507243989.22% to $16996.7 billion in 2022, then climbed by 4.15% to $17701.6 billion in 2023, then fell by 24.63% to $13340.9 billion in 2024, then tumbled by 86.14% to $1849.5 billion in 2025.
  • Business Quant data shows ADAG's Total Debt at $1849.5 billion in Q4 2025, $4.5 million in Q2 2025, and $13340.9 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 1.07 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.43 Bn 27.59 Bn - 9.34 Bn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 546.77 Mn
10 Adagene 213.60 Mn 213.60 Mn - 5.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.73 Mn
Dec 31, 2025 6.12 Mn
Jun 30, 2025 6.64 Mn
Dec 31, 2024 18.21 Mn
Jun 30, 2024 20.54 Mn
Dec 31, 2023 21.94 Mn
Jun 30, 2023 24.94 Mn
Dec 31, 2022 27.77 Mn
Jun 30, 2022 16.57 Mn
Dec 31, 2021 7.49 Mn
Jun 30, 2021 7.67 Mn
Dec 31, 2020 7.98 Mn
Dec 31, 2019 2.56 Mn